Weiss Amir (CIK 1897057) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-25). Recent activity: Sell TEVA (6,945 shares), Buy TEVA (2,500 shares), Sell TEVA (2,500 shares), Sell TEVA (10,679 shares), Buy TEVA (3,537 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-25 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | Sell | 6,945 | $261,224 |
| 2026-08-25 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | Buy | 2,500 | $49,025 |
| 2026-08-25 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | Sell | 2,500 | $94,077 |
| 2026-05-07 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | Sell | 10,679 | $384,444 |
| 2026-03-09 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | Buy | 3,537 | $0 |
| 2026-03-06 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | Buy | 10,679 | $0 |
| 2026-03-06 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | Buy | 5,650 | $0 |
| 2026-03-05 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | Buy | 5,179 | $0 |
| 2025-12-18 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | Sell | 12,300 | $371,460 |
| 2025-11-10 | TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) | Chief Accounting Officer | Sell | 12,300 | $300,612 |
来源：SEC Form 4 申报文件 · 截至 2026-08-25